We spoke to Allison Watson (Ring20 Research & Support UK CIO) about her journey following her son’s diagnosis of a rare form ...

What’s been going on in the life sciences world this week? Check out Week in Brief for an overview of the biggest news.

Lyndsey: Hi everybody, and welcome back to FoGCast. Manny and myself are diving into the future of healthcare with a true pioneer. Anu Acharya is described as a serial entrepreneur and is the ...

What’s been going on in the life sciences world this week? Check out Week in Brief for an overview of the biggest news.

The Festival of Genomics and Biodata is just around the corner, and we’ve had the opportunity to sit down with some of our expert speakers to get a sneak peek into what they’ll be discussing at the ...

Are collaboration and consortia the key to reducing cost and improving confidence in liquid biopsies? If the ultimate goal of patient benefit is to be realised, all stakeholders must be convinced of ...

Written by Arpita Kulkarni (Director of the Functional Genomics and Bioinformatics Core at HMS/BIDMC). Across the life sciences, a quiet anxiety is growing: what is the role of the experimental ...

Mark your calendar for Thursday, 5th, 12th, and 19th June 2025. Epigenetic regulation is profoundly complex – varying across cell types, biological contexts, and time. This complexity creates a ...

The metabolome consists of all the small molecules, or metabolites, which are components and products of biochemical reactions taking place within the body. Given its dynamic nature, metabolomics is a ...

This feature was written using content from out recenty published Proteomics Playbook, which you can download for FREE here. The sequence of a protein is critical as it largely dictates the protein’s ...

Analysis of proteins is not simple. Unlike DNA, there is incredible diversity in the concentration and variety of proteins created by a cell at any given moment. In our Proteomics Playbook we outline ...

At our recent FOG Live: Single Cell and Spatial event, Aridiman Pandit (Senior Principal Research Scientists, AbbVie) explored how single-cell and multi-omics technologies can revolutionise drug ...